Celularity to Present at the B. Riley Securities Virtual Oncology Investor Conference
Share this article Share this article FLORHAM PARK, N.J., Jan. 20, 2021 /PRNewswire/ -- Celularity Inc., a clinical stage cell therapeutics company focused on the development of innovative allogeneic placenta-derived cellular therapies, today announced that Robert J. Hariri, M.D., Ph.D., Founder, Chairperson and Chief Executive Officer of Celularity and members of the management team will be participating in a fireside chat at the B. Riley Virtual Oncology Investor Conference on Thursday, January 21, 2021, at 3:30 p.m. ET The live audience is limited to institutional investors, investor rela...